$111 Million is the total value of ECLIPSE VENTURES, LLC's 3 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ENOVIX CORPORATION | $94,335,730 | -59.1% | 7,583,258 | -39.7% | 85.02% | -1.3% | |
| OWLET INC | $15,927,214 | -47.8% | 28,492,332 | 0.0% | 14.36% | +26.1% | ||
| LHDX | LUCIRA HEALTH INC | $690,841 | -89.5% | 6,223,795 | 0.0% | 0.62% | -74.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OWLET INC | 7 | Q2 2023 | 100.0% |
| ENOVIX CORPORATION | 6 | Q1 2023 | 91.4% |
| LUCIRA HEALTH INC | 6 | Q1 2023 | 8.9% |
| OWLET INC | 1 | Q3 2023 | 100.0% |
View ECLIPSE VENTURES, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR/A | 2022-04-19 |
| 13F-HR | 2022-02-09 |
View ECLIPSE VENTURES, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.